Emerging Options and Future Strategies in Immunotherapy for Advanced Lung Squamous Cell Carcinoma
{{output}}
Advanced-stage lung squamous cell carcinoma (LUSC) remains a therapeutic challenge. Although immune checkpoint inhibitors (ICIs) have revolutionized LUSC treatment, only a small subset of LUSC patients can achieve durable clinical benefits, underscoring the ne... ...
